Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity TrialFrancesco Schettini, Daniele Generali, Manuela Milani et al.|Frontiers in Oncology|2021Cited by 19
Computational reactive–diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving OlaparibFrancesco Schettini, Daniele Generali, Maria Valeria De Bonis et al.|Scientific Reports|2023Cited by 6
Assessing the long-term prognostic ability of the 70 gene expression signature MammaPrint in an Italian single-center prospective cohort study of early-stage intermediate-risk breast cancer patientsDaniele Generali, Stannie J. van den Ende, Andrea Rocca et al.|Heliyon|2024Cited by 1